Indiva (TSXV:NDVA)

  • Symbol:TSXV:NDVA
  • Ticker 2:OTC:NDVAF
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Neil Marotta
  • Founded:2015
Categories:

Indiva (TSXV:NDVA) Stock Price

Disclaimer: Past performance is not an indicator of future performance.

Indiva (TSXV:NDVA) Company Overview

Indiva (TSXV:NDVA) (US:NDVAF) is a licensed producer of medical-grade cannabis. Based in London, Ontario, Indiva's state-of-the-art facility includes environmentally-conscious grow rooms, in addition to a production and manufacturing space that produces safe, high-quality cannabis products.

With an operational goal of delivering its suite of global cannabis brands to Canadians and cannabis enthusiasts around the world, Indiva recently entered into the European cannabis market.

After acquiring complete ownership of medical cannabis cultivation and handling license in Denmark, under the Danish Medicines Agency development scheme, Indiva management has confirmed plans for expansion.

As cannabis laws continue to become more liberal globally, Indiva will be including an expanded range of safe edibles and additional client-friendly cannabis products. Indiva wants you to "have your weed, and eat it too."

"Our mission is to normalize the use of cannabis by setting new standards for quality, creativity and sustainability."

The Company produces and distributes Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems— as well as the award-winning Bhang Chocolate—in Canada, along with other derivative products through license agreements and joint ventures.

Having recently added 10,000 square feet of production space, Niel Marotta, President and Chief Executive Officer, expects the Company to "enter new markets and deliver new, innovative products that already have significant market share in mature markets south of the border."

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Become a Patron below and support us in covering the latest marijuana news!